No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Alimta is a chemotherapy drug used to treat non-small cell lung cancer (NSCLC). It is a platinum-based drug, meaning it contains a platinum atom in its chemical structure. Alimta is used in combination with other drugs to treat NSCLC, and is often used in combination with cisplatin. Alimta is also used to treat mesothelioma, a type of cancer caused by exposure to asbestos.
Alimta is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2004. Since then, it has become a popular treatment for NSCLC and mesothelioma. Alimta is marketed by Eli Lilly and Company, and is available in both generic and brand-name versions. Other companies that produce Alimta include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more
